ask="1.310"
ask_size="3500"
average_daily_volume="1438850"
bid="1.230"
bid_size="2500"
book_value="1.355"
change="+0.004"
change_from_200_day_moving_average="-0.123"
change_from_50_day_moving_average="0.227"
change_from_52_week_high="-5.486"
change_From_52_week_low="0.453"
change_in_percent="+0.315%"
close="1.274"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.601"
ebitda="-29.80M"
eps_estimate_current_year="-1.480"
eps_estimate_next_quarter="-0.280"
eps_estimate_next_year="-1.210"
ex_dividend_date="N/A"
float_shares="13994000"
high="1.330"
high_52_weeks="6.760"
last_trade_date="1/26/2017"
last_trade_price="1.274"
last_trade_size="375"
last_trade_time="3:59pm"
low="1.220"
low_52_weeks="0.821"
market_capitalization="25.10M"
moving_average_200_day="1.397"
moving_average_50_day="1.047"
name="Marinus Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="3.330"
open="1.270"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-8.831%"
percent_change_from_50_day_moving_average="+21.719%"
percent_change_from_52_week_high="-81.154%"
percent_change_from_52_week_low="+55.120%"
previous_close="1.270"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.937"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="19705000"
short_ratio="0.960"
stock_exchange="NGM"
symbol="MRNS"
volume="2005717"
weeks_range_52="0.821 - 6.760"
